We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
-24.17%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$95.4M
(-31%)
Cap. Flow
-$9.59M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
60.08%
Holding
113
New
8
Increased
22
Reduced
12
Closed
11
Avg Time Held
2.4
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$6.25M |
| 2 |
LKQ Corp
LKQ
|
+$5.44M |
| 3 |
TSG
The Stars Group Inc.
TSG
|
+$4.72M |
| 4 |
NBL
Noble Energy, Inc.
NBL
|
+$2.46M |
| 5 |
Upland Software
UPLD
|
+$2.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$11.4M |
| 2 |
MITL
Mitel Networks Corporation
MITL
|
+$7.9M |
| 3 |
Anadarko Petroleum
APC
|
+$4.35M |
| 4 |
AbbVie
ABBV
|
+$4.18M |
| 5 |
Newell Brands
NWL
|
+$4.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.79% |
| 2 | Technology | 10.85% |
| 3 | Financials | 9.97% |
| 4 | Energy | 9.1% |
| 5 | Consumer Discretionary | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Community Healthcare Trust
CHCT
$379M
| $1.73M | 0.81% |
60,000
| – | – |
2015 Q2
14 quarters
|
|
|
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.55M | 0.73% |
39,828
+2,337
| +6% | +$91.8K |
2017 Q3
5 quarters
|
|
|
STML
28
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.48M | 0.7% |
155,795
+50,508
| +48% | +$655K |
2017 Q1
7 quarters
|
|
|
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.44M | 0.68% |
73,640
| – | – |
2018 Q2
2 quarters
|
|
30
AllianceBernstein
AB
$3.21B
| $1.38M | 0.65% |
50,500
| – | – |
2013 Q2
22 quarters
|
|
31
CoreCivic
CXW
$3.03B
| $1.34M | 0.63% |
75,000
| – | – |
2016 Q4
8 quarters
|
|
|
EIGR
32
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.33M | 0.63% |
4,378
+1,022
| +30% | +$330K |
2017 Q3
5 quarters
|
|
33
DELISTED
Radius Health, Inc.
RDUS
| $1.27M | 0.6% |
77,269
+55,269
| +251% | +$931K |
2018 Q3
1 quarter
|
|
|
AIMT
34
DELISTED
Aimmune Therapeutics
AIMT
| $1.26M | 0.59% |
52,857
+8,705
| +20% | +$225K |
2017 Q3
5 quarters
|
|
35
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.18M | 0.55% |
613,447
+59,972
| +11% | +$172K |
2017 Q1
7 quarters
|
|
36
Xenon Pharmaceuticals
XENE
$3.24B
| $1.09M | 0.51% |
173,390
| – | – |
2017 Q3
5 quarters
|
|
37
Verizon
VZ
$186B
| $1.03M | 0.48% |
18,311
| – | – |
2014 Q2
18 quarters
|
|
|
QTNT
38
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.02M | 0.48% |
4,175
| – | – |
2017 Q4
4 quarters
|
|
|
CNCE
39
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.01M | 0.47% |
80,300
+14,300
| +22% | +$197K |
2017 Q3
5 quarters
|
|
|
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
| $949K | 0.45% |
26,039
| – | – |
2017 Q3
5 quarters
|
|
41
Johnson & Johnson
JNJ
$616B
| $940K | 0.44% |
7,280
| – | – |
2013 Q2
22 quarters
|
|
42
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$76.6M
| $857K | 0.4% |
35,000
| – | – |
2017 Q3
5 quarters
|
|
43
Ryman Hospitality Properties
RHP
$8.69B
| $827K | 0.39% |
12,400
| – | – |
2013 Q2
22 quarters
|
|
44
Canadian Natural Resources
CNQ
$111B
| $781K | 0.37% |
66,059
| – | – |
2017 Q2
6 quarters
|
|
|
XLRN
45
DELISTED
Acceleron Pharma
XLRN
| $758K | 0.36% |
17,400
+1,000
| +6% | +$50K |
2018 Q2
2 quarters
|
|
|
FOMX
46
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $740K | 0.35% |
+206,200
| New | +$897K |
2018 Q4
0 quarters
|
|
|
47
DELISTED
Anadarko Petroleum
APC
| $699K | 0.33% |
15,960
-77,050
| -83% | -$4.35M |
2013 Q2
22 quarters
|
|
48
Kimberly-Clark
KMB
$35.1B
| $684K | 0.32% |
6,000
| – | – |
2017 Q3
5 quarters
|
|
49
Mondelez International
MDLZ
$81.6B
| $636K | 0.3% |
15,900
| – | – |
2013 Q2
22 quarters
|
|
50
Coca-Cola
KO
$404B
| $635K | 0.3% |
13,400
| – | – |
2013 Q2
22 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q4 2018 Portfolio in Review
As of Q4 2018, David M. Knott held 113 positions worth $213M, down 31% from $308M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
David M. Knott withdrew a net $9.59M in Q4 2018, closing 11 positions and reducing 12 holdings. Its most notable exit was Mitel Networks Corporation, an estimated $7.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Financials.
Against the trend, David M. Knott opened a new position in The Stars Group Inc. worth $4M.
- David M. Knott's largest Q4 2018 buy was The Stars Group Inc.: 241,920 shares worth $4M.
- David M. Knott added most to Apollo Global Management in Q4 2018, an estimated $6.25M increase.
- David M. Knott's biggest Q4 2018 reduction was Dell, cutting an estimated $11.4M.
- David M. Knott fully exited Mitel Networks Corporation in Q4 2018, selling an estimated $7.9M.
- David M. Knott's ten largest holdings make up 60% of its $213M portfolio in Q4 2018.
- David M. Knott opened 8 new positions and closed 11 in Q4 2018.
- David M. Knott's portfolio value fell 31% quarter-over-quarter to $213M.
Based on David M. Knott's 13F filing for Q4 2018, filed 12 Feb 2019.